Safe Driving After Propofol Sedation
Copyright © 2016 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved..
PURPOSE: Propofol is a short-acting medication with fast cognitive and psychomotor recovery. However, patients are usually instructed not to drive a motor vehicle for 24 hours after receiving propofol. The purpose of this article was to review the evidence examining when it is safe to drive after receiving propofol for sedation for diagnostic and surgical procedures.
DESIGN: This is a systematic review of the literature.
METHODS: A search of the literature was conducted using Google Scholar, PubMed, and the Cochrane Library for the time period 1990 to 2015.
FINDINGS: Two randomized controlled trials and two observational studies met the inclusion criteria. Using a simulator, investigators examined driving ability of subjects who received modest doses (about 100 mg) of propofol for endoscopic procedures and surveyed subjects who drove immediately after discharge. There were methodological concerns with the studies such as small sample sizes, modest doses of propofol, and three of the four studies were done in Japan by the same group of investigators limiting generalizability.
CONCLUSION: This limited research suggests that it may be safe for patients to drive sooner than 24 hours after receiving propofol. However, large multicenter trials using heterogenous samples using a range of propofol doses are needed to support an evidence-based revision to the current discharge guidelines for patients receiving propofol.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses - 32(2017), 5 vom: 22. Okt., Seite 464-471 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Summerlin-Grady, Lee [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Automobile |
|---|
| Anmerkungen: |
Date Completed 31.05.2018 Date Revised 31.05.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jopan.2016.01.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM276092686 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM276092686 | ||
| 003 | DE-627 | ||
| 005 | 20231225011215.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jopan.2016.01.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0920.xml |
| 035 | |a (DE-627)NLM276092686 | ||
| 035 | |a (NLM)28938982 | ||
| 035 | |a (PII)S1089-9472(16)30317-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Summerlin-Grady, Lee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safe Driving After Propofol Sedation |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.05.2018 | ||
| 500 | |a Date Revised 31.05.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a PURPOSE: Propofol is a short-acting medication with fast cognitive and psychomotor recovery. However, patients are usually instructed not to drive a motor vehicle for 24 hours after receiving propofol. The purpose of this article was to review the evidence examining when it is safe to drive after receiving propofol for sedation for diagnostic and surgical procedures | ||
| 520 | |a DESIGN: This is a systematic review of the literature | ||
| 520 | |a METHODS: A search of the literature was conducted using Google Scholar, PubMed, and the Cochrane Library for the time period 1990 to 2015 | ||
| 520 | |a FINDINGS: Two randomized controlled trials and two observational studies met the inclusion criteria. Using a simulator, investigators examined driving ability of subjects who received modest doses (about 100 mg) of propofol for endoscopic procedures and surveyed subjects who drove immediately after discharge. There were methodological concerns with the studies such as small sample sizes, modest doses of propofol, and three of the four studies were done in Japan by the same group of investigators limiting generalizability | ||
| 520 | |a CONCLUSION: This limited research suggests that it may be safe for patients to drive sooner than 24 hours after receiving propofol. However, large multicenter trials using heterogenous samples using a range of propofol doses are needed to support an evidence-based revision to the current discharge guidelines for patients receiving propofol | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a automobile | |
| 650 | 4 | |a driving | |
| 650 | 4 | |a procedures | |
| 650 | 4 | |a propofol | |
| 650 | 4 | |a sedation | |
| 650 | 7 | |a Hypnotics and Sedatives |2 NLM | |
| 650 | 7 | |a Propofol |2 NLM | |
| 650 | 7 | |a YI7VU623SF |2 NLM | |
| 700 | 1 | |a Austin, Paul N |e verfasserin |4 aut | |
| 700 | 1 | |a Gabaldon, Dion A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses |d 1998 |g 32(2017), 5 vom: 22. Okt., Seite 464-471 |w (DE-627)NLM08930408X |x 1532-8473 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2017 |g number:5 |g day:22 |g month:10 |g pages:464-471 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jopan.2016.01.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2017 |e 5 |b 22 |c 10 |h 464-471 | ||